Credit Suisse Starts Pharmacyclics (PCYC) at Outperform
Tweet Send to a FriendGet Alerts PCYC Hot Sheet
Price: $85.61 +0.01%
Rating Summary:
8 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
8 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade PCYC Now!
Credit Suisse initiates coverage on Pharmacyclics (NASDAQ: PCYC) with a Outperform. PT $79.00.
For an analyst ratings summary and ratings history on Pharmacyclics click here. For more ratings news on Pharmacyclics click here.
Shares of Pharmacyclics closed at $65.15 yesterday, with a 52 week range of $15.70-$70.48.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Pharmacyclics click here. For more ratings news on Pharmacyclics click here.
Shares of Pharmacyclics closed at $65.15 yesterday, with a 52 week range of $15.70-$70.48.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Deutsche Bank Resumes CenterPoint Energy (CNP) at Hold
- Roth Capital Resumes Kid Brands (KID) at Neutral
- Deutsche Bank Starts Kodiak Oil & Gas (KOG) at Hold
Create E-mail Alert Related Categories
New CoverageRelated Entities
Credit Suisse
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
